CSIMarket Company Name, Ticker, Customers, else..
 
Ligand Pharmaceuticals Incorporated  (NASDAQ: LGND)
 

LGND's Market share relative to its competitors, as of Q3 2026

As of Q3 2026 (Revenue in Millions of $)

Date modified: 2026-09-29T04:45:26+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months
Q3 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE
A Quarter Before
Q2 2026
Ligand Pharmaceuticals Incorporated 253.83 0.04% 0.05 % 0.02 %
Abcellera Biologics Inc 67.86 0.01% 0.01% 0.00%
Pelthos Therapeutics Inc 43.30 0.01% 0.01% 0.00%
Legend Biotech Corporation 1,028.90 0.16% 0.16% 0.00%
Nanoviricides inc 0.00 0.00% 0.00% 0.00%
Nurix Therapeutics Inc 701.94 0.11% 0.39% 0.00%
73 more competitors available

Sign in to see all competitors for Ligand Pharmaceuticals Incorporated.

Sign In Create Free Account



LGND's Market share relative to its competitors, as of Q3 2026 within the Major Pharmaceutical Preparations Industry
As of Q3 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE

Q2 2026
Ligand Pharmaceuticals Incorporated 0.04% 0.05% 0.05 % 0.02 %
Abcellera Biologics Inc 0.01% 0.01% 0.01% 0.00%
Legend Biotech Corporation 0.18% 0.12% 0.18% 0.12%
Nanoviricides inc 0.00% 0.00% 0.00% 0.00%
Nurix Therapeutics Inc 0.12% 0.02% 0.45% 0.00%
Nuvalent Inc 0.00% 0.00% 0.00% 0.00%
69 more companies available

Sign in to see all industry competitors for Ligand Pharmaceuticals Incorporated.

Sign In Create Free Account



LGND's Market share relative to its competitors, as of Q3 2026 within the Healthcare Sector
As of Q3 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE

Q2 2026
Ligand Pharmaceuticals Incorporated 0.04% 0.05% 0.05 % 0.02 %
Abcellera Biologics Inc 0.01% 0.01% 0.01% 0.00%
Pelthos Therapeutics Inc 0.01% 0.00% 0.01% 0.00%
Legend Biotech Corporation 0.16% 0.11% 0.16% 0.11%
Nanoviricides inc 0.00% 0.00% 0.00% 0.00%
Nurix Therapeutics Inc 0.11% 0.01% 0.39% 0.00%
73 more companies available

Sign in to see all sector competitors for Ligand Pharmaceuticals Incorporated.

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Ligand Pharmaceuticals Incorporated's market divisions, geographic dispersion, segments, products, and services, visit Ligand Pharmaceuticals Incorporated's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.